1. Home
  2. TMDX vs RUN Comparison

TMDX vs RUN Comparison

Compare TMDX & RUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • RUN
  • Stock Information
  • Founded
  • TMDX 1998
  • RUN 2007
  • Country
  • TMDX United States
  • RUN United States
  • Employees
  • TMDX N/A
  • RUN N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RUN Industrial Machinery/Components
  • Sector
  • TMDX Health Care
  • RUN Miscellaneous
  • Exchange
  • TMDX Nasdaq
  • RUN Nasdaq
  • Market Cap
  • TMDX 4.8B
  • RUN 2.0B
  • IPO Year
  • TMDX 2019
  • RUN 2015
  • Fundamental
  • Price
  • TMDX $128.97
  • RUN $8.99
  • Analyst Decision
  • TMDX Buy
  • RUN Buy
  • Analyst Count
  • TMDX 10
  • RUN 22
  • Target Price
  • TMDX $127.33
  • RUN $13.69
  • AVG Volume (30 Days)
  • TMDX 838.7K
  • RUN 30.3M
  • Earning Date
  • TMDX 07-30-2025
  • RUN 08-05-2025
  • Dividend Yield
  • TMDX N/A
  • RUN N/A
  • EPS Growth
  • TMDX N/A
  • RUN N/A
  • EPS
  • TMDX 1.41
  • RUN N/A
  • Revenue
  • TMDX $488,227,000.00
  • RUN $2,083,802,000.00
  • Revenue This Year
  • TMDX $34.07
  • RUN $11.20
  • Revenue Next Year
  • TMDX $20.76
  • RUN $11.43
  • P/E Ratio
  • TMDX $92.35
  • RUN N/A
  • Revenue Growth
  • TMDX 64.43
  • RUN N/A
  • 52 Week Low
  • TMDX $55.00
  • RUN $5.38
  • 52 Week High
  • TMDX $177.37
  • RUN $22.26
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 59.35
  • RUN 53.13
  • Support Level
  • TMDX $120.36
  • RUN $7.23
  • Resistance Level
  • TMDX $133.49
  • RUN $8.62
  • Average True Range (ATR)
  • TMDX 5.58
  • RUN 0.75
  • MACD
  • TMDX -1.35
  • RUN 0.09
  • Stochastic Oscillator
  • TMDX 60.26
  • RUN 62.61

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About RUN Sunrun Inc.

Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed either by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.

Share on Social Networks: